Javidialsaadi M, Luy D, Smith H, Cecia A, Yang S, Germanwala A
J Clin Med. 2025; 14(4).
PMID: 40004632
PMC: 11856613.
DOI: 10.3390/jcm14041101.
Palavani L, Mitre L, Nogueira B, Honorato F, Ferreira M, Farias C
Surg Neurol Int. 2025; 16:22.
PMID: 39926460
PMC: 11799707.
DOI: 10.25259/SNI_836_2024.
van Essen M, Nicheperovich A, Schuster-Bockler B, Becker E, Jacob J
Neurooncol Adv. 2025; 7(1):vdae218.
PMID: 39896075
PMC: 11783571.
DOI: 10.1093/noajnl/vdae218.
Yi M, Lee J, Moon S, So E, Bang G, Moon K
Biomedicines. 2025; 13(1).
PMID: 39857798
PMC: 11763300.
DOI: 10.3390/biomedicines13010216.
Zhang J, Zhang J, Yang C
J Transl Med. 2025; 23(1):52.
PMID: 39806481
PMC: 11727735.
DOI: 10.1186/s12967-024-06063-0.
Brain-Derived Neurotrophic Factor (BDNF) as a Potential Biomarker in Brain Glioma: A Systematic Review and Meta-Analysis.
Hasani F, Masrour M, Khamaki S, Jazi K, Ghoodjani E, Teixeira A
Brain Behav. 2025; 15(1):e70266.
PMID: 39789839
PMC: 11726635.
DOI: 10.1002/brb3.70266.
Extracranial and nonvaginal extragonadal malignant germ cell tumors: 12 cases at a Chinese institution over the last 38 years.
Ma X, Gan J, Cao D, Peng P
Arch Gynecol Obstet. 2025; .
PMID: 39774707
DOI: 10.1007/s00404-024-07889-1.
Unraveling molecular signatures and prognostic biomarkers in glioblastoma: a comprehensive study on treatment resistance and personalized strategies.
Xue J, Zhang J, Zhu J
Discov Oncol. 2024; 15(1):743.
PMID: 39630160
PMC: 11618281.
DOI: 10.1007/s12672-024-01649-y.
Neddylation of protein, a new strategy of protein post-translational modification for targeted treatment of central nervous system diseases.
Wu Q, Geng Z, Lu J, Wang S, Yu Z, Wang S
Front Neurosci. 2024; 18:1467562.
PMID: 39564524
PMC: 11573765.
DOI: 10.3389/fnins.2024.1467562.
Unveiling the therapeutic promise of EphA2 in glioblastoma: a comprehensive review.
Qiu C, Sun N, Zeng S, Chen L, Gong F, Tian J
Discov Oncol. 2024; 15(1):501.
PMID: 39331302
PMC: 11436538.
DOI: 10.1007/s12672-024-01380-8.
Local Delivery of Irinotecan to Recurrent GBM Patients at Reoperation Offers a Safe Route of Administration.
McConville C, Lastakchi S, Al Amri A, Ngoga D, Fayeye O, Cruickshank G
Cancers (Basel). 2024; 16(17).
PMID: 39272866
PMC: 11393903.
DOI: 10.3390/cancers16173008.
Survival analysis and associated factors of highgrade glioma patients.
Barrera L, Ortiz L, Grisales H, Camargo M
Biomedica. 2024; 44(2):191-206.
PMID: 39088535
PMC: 11374120.
DOI: 10.7705/biomedica.6742.
Controlled Study of Pre- and Postoperative Headache in Patients with Sellar Masses (HEADs-uP Study).
Slagboom T, Boertien T, Bisschop P, Fliers E, Baaijen J, Hoogmoed J
Endocrinol Diabetes Metab. 2024; 7(4):e496.
PMID: 39001600
PMC: 11245567.
DOI: 10.1002/edm2.496.
Astrocytoma with high-grade features and MYBL1-MMP16 fusion.
Alarfaj A, Pollock B, Sagga A, Das S, Chow M
Surg Neurol Int. 2024; 15:203.
PMID: 38974570
PMC: 11225526.
DOI: 10.25259/SNI_465_2023.
Enhancing structural diversity through chemical engineering of Ambrosia tenuifolia extract for novel anti-glioblastoma compounds.
Adessi T, Wagner P, Bisogno F, Nicotra V, Guido M, Garcia M
Sci Rep. 2024; 14(1):14229.
PMID: 38902325
PMC: 11190268.
DOI: 10.1038/s41598-024-63639-y.
Pediatric Solid Cancers: Dissecting the Tumor Microenvironment to Improve the Results of Clinical Immunotherapy.
Belgiovine C, Mebelli K, Raffaele A, De Cicco M, Rotella J, Pedrazzoli P
Int J Mol Sci. 2024; 25(6).
PMID: 38542199
PMC: 10970338.
DOI: 10.3390/ijms25063225.
Management of glioblastoma in elderly patients: A review of the literature.
Mazarakis N, Robinson S, Sinha P, Koutsarnakis C, Komaitis S, Stranjalis G
Clin Transl Radiat Oncol. 2024; 46:100761.
PMID: 38500668
PMC: 10945210.
DOI: 10.1016/j.ctro.2024.100761.
Automated volumetry of meningiomas in contrast-enhanced T1-Weighted MRI using deep learning.
Iwata T, Hirayama R, Yamada S, Kijima N, Okita Y, Kagawa N
World Neurosurg X. 2024; 22:100353.
PMID: 38455247
PMC: 10918322.
DOI: 10.1016/j.wnsx.2024.100353.
Wnt/β-catenin-driven EMT regulation in human cancers.
Xue W, Yang L, Chen C, Ashrafizadeh M, Tian Y, Sun R
Cell Mol Life Sci. 2024; 81(1):79.
PMID: 38334836
PMC: 10857981.
DOI: 10.1007/s00018-023-05099-7.
Surgical site infections after glioblastoma surgery: boon or bane?.
Hounchonou H, Bajgora G, Esmaeilzadeh M, Hartmann C, Krauss J
J Cancer Res Clin Oncol. 2024; 150(2):36.
PMID: 38279060
PMC: 10817840.
DOI: 10.1007/s00432-023-05528-x.